European UPC Patent Cases
1,592 decisions indexed
Page 6 of 54 · 1,592 total
Valeo Systèmes d’Essuyages v.Robert Bosch Doo Bograd, Robert Bosch France S.A.S, Robert Bosch GmbH, Robert Bosch S.A, ROBERT BOSCH PRODUKTIE S.A., BOSCH AUTOMOTIVE PRODUCTS (CHANGSHA) CO., LTD.
This UPC procedural order addressed a preliminary objection regarding jurisdiction in an infringement case involving Valeo Systèmes d’Essuyages against various Robert Bosch entities. The court rejected the argument that the Central Division had universal competence due to cross-border infringements and instead applied Article 33(1)(b) of the UPC Agreement, transferring the case to the local division of Düsseldorf. This decision highlights the strict application of jurisdictional rules when defendants are domiciled within contracting states.
ZTE Corporation v.Samsung Electronics Co., Ltd.
In this procedural order concerning an infringement action, the UPC Local Division in Mannheim addressed requests from Samsung (Defendants) to introduce new evidence and pleadings related to ongoing license negotiations and third-party agreements. The Court dismissed the broad requests for further written submissions and production orders, citing concerns over 'ping-pong' effects and the timing of the evidence. However, recognizing the dynamic nature of FRAND licensing, the Court granted a limited window for parties to submit briefs on new developments before the oral hearing, ensuring that all relevant facts can be considered during the merits phase.
Sun Patent Trust v.Shenzhen Transsion Holdings Co, Ltd
In a procedural ruling from the Mannheim Local Court, Sun Patent Trust withdrew its infringement claim against multiple defendants, including Shenzhen Transsion Holdings. The parties reached an agreement regarding the termination of the case and cost allocation. While the core dispute was dropped, the court confirmed the withdrawal and ordered a partial refund of the initial court fees to the claimant.
Atlas Global Technologies GmbH v.Vantiva SA
In a procedural decision, the Düsseldorf Local Division accepted the withdrawal of an infringement claim brought by Atlas Global Technologies GmbH against Vantiva SA and its affiliates. Concurrently, the counterclaim seeking revocation of EP 3186937 was also withdrawn. The court formally terminated both proceedings based on the parties' mutual agreement. This case highlights how procedural agreements between litigants can lead to the early conclusion of complex UPC actions.
Insulet Corporation v.EOFLow Co., Ltd.
This UPC Court of Appeal decision addressed a procedural request for access to written pleadings and evidence. The court balanced the general interest in public access against concerns regarding confidentiality, personal data protection (GDPR), and copyright. Ultimately, limited access was granted to the law firm representing one party, provided all personal data was redacted.
Atlas Global Technologies GmbH v.Vantiva SA
In a procedural ruling before the Düsseldorf Local Division of the UPC, Atlas Global Technologies GmbH withdrew its infringement claim against Vantiva SA and its affiliates. Simultaneously, the defendants successfully withdrew their counterclaim seeking revocation of the patent EP 3 353 901. The court accepted both withdrawals, declaring the proceedings terminated. This case highlights how procedural agreements between parties can lead to a swift conclusion in complex UPC litigation, focusing on mutual consent rather than substantive merits.
InterDigital VC Holdings, Inc. v.Amazon.com, Inc.
In a significant ruling concerning SEP licensing and anti-suit injunctions, the UPC Local Division Mannheim confirmed an order preventing Amazon from pursuing contractual claims in UK courts. The applicants (InterDigital) successfully defended their attempt to enforce measures designed to ensure that patent infringement proceedings before the UPC are not undermined by external legal actions. This decision reinforces the UPC's jurisdiction and its ability to manage complex cross-border disputes involving standard-setting organizations.
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. v.HMD Global Oy
This procedural order addressed a dispute over the production of evidence in an alleged patent infringement case concerning MPEG-4/AAC standards. The Defendant sought access to historical licensing agreements, arguing they were necessary for assessing FRAND compliance and potential exhaustion of rights. Conversely, the Claimant resisted disclosure of its own current license agreement due to confidentiality obligations. The Court partially sided with both parties, rejecting the broad disclosure requests while compelling the submission of a specific, highly confidential contract.
GXD-Bio Corporation v.Myriad International GmbH (and associated Myriad entities)
In a significant decision, the UPC Local Division Munich revoked European Patent EP 3 346 403. The patent covered methods for quantifying gene expression in breast cancer tissue using RT-PCR and normalization to endogenous reference genes. Despite GXD-Bio Corporation's infringement claims against Myriad International GmbH and its subsidiaries regarding their EndoPredict-Test, the court dismissed the infringement action following the revocation of the patent. This ruling underscores the dual nature of UPC proceedings, where a successful counterclaim for revocation can immediately extinguish an associated infringement claim.
Centripetal Limited v.Palo Alto Networks, Inc.
In a significant decision for cybersecurity IP, the UPC Local Division Mannheim revoked European Patent EP 3 652 914 B1. The patent, which covered methods for accelerating cyberanalysis workflows using machine learning and threat logs, was invalidated due to lack of inventive step in its amended claims. This revocation led directly to the dismissal of the concurrent infringement action brought by Centripetal Ltd. against Palo Alto Networks, Inc., highlighting the critical interplay between validity challenges and enforcement actions within the UPC framework.
LiNA Medical AG v.Schultz Medical (UK) Ltd.
This Düsseldorf Local Division order addresses procedural issues arising from an application to preserve evidence in a medical device patent case. The court emphasized that defendants must actively utilize provided CMS access codes and appoint representatives promptly if they wish to comment on confidentiality interests related to expert reports. Since the respondent failed to log into the CMS, the court proceeded with disclosing the unredacted expert description to the applicant while simultaneously revoking the evidence preservation measures unless the main infringement proceedings were quickly initiated.
UERAN Technology LLC v.Xiaomi Corporation, Xiaomi Communications Co., Ltd., Xiaomi Inc., Xiaomi Technology Netherlands B.V., Xiaomi Technology Germany GmbH, Xiaomi Technology France S.A.S., Xiaomi Technology Italy S.R.L.
This entry represents a case file involving UERAN Technology LLC against Xiaomi Corporation. However, the provided text is merely an excerpt showing the signatures and dates of the involved parties' counsel and judges/participants. Consequently, no substantive information regarding the infringement claims, patent scope, or final judgment can be determined from this snippet.
Grundfos Holding A/S v.Hefei Xinhu Canned Motor Pump Co., Ltd
This UPC appellate decision clarifies the strict application of Article 69(4) EPC regarding cost security. The court ruled that in appeal proceedings, only the appellant is considered the applicant for costs purposes. Consequently, Grundfos (the appellee/claimant in this specific context) was permitted to request security against Hefei (the appellant/respondent). This ruling reinforces the principle that cost security measures are designed to protect the party initiating the legal action from potential non-payment.
Hewlett-Packard Development Company, L.P. v.Andreas Rentmeister e.K.
HP Development Company successfully obtained provisional measures and a preliminary injunction against Andreas Rentmeister e.K. in the UPC regarding infringement of its 'Logic circuitry' patent (EP 3 835 965 B1). The case, filed under R. 206 RoP, targeted counterfeit printer cartridges (types 924 and 937) sold by both German and Chinese defendants. Crucially, the court also imposed significant penalty payments on the Chinese defendant to enforce compliance with the provisional measures, demonstrating a strong enforcement stance in UPC proceedings.
Docket Navigator v.Sumi Agro Limited; Sumi Agro Europe Limited; Syngenta Limited
This UPC Court of Appeal decision addressed a request by the litigation intelligence platform, Docket Navigator, seeking access to confidential written pleadings and evidence in an concluded case. The court ruled that the commercial interest of making these documents available to subscribers does not meet the threshold for protection under Article 45 UPCA. Furthermore, the requirement for representation was deemed essential to safeguard procedural integrity. This ruling reinforces the UPC's commitment to maintaining judicial confidentiality unless a legitimate public interest is demonstrated.
Ecovacs Robotics Co., Ltd. v.Roborock (HK) Limited
In this UPC decision, the Düsseldorf Local Division addressed a request for an ex-parte order concerning the inspection and preservation of evidence related to robot localization technology. The court ultimately revoked the existing provisional measure because the applicant's submission was deemed incomplete and misleading regarding the core facts. This ruling serves as a strong warning to applicants seeking urgent interim relief that procedural integrity is paramount, especially when relying on ex-parte proceedings.
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. v.HMD Global Oy
This procedural order addressed a dispute over evidence disclosure in an ongoing patent infringement and FRAND assessment case concerning MPEG-4/AAC technology. The Defendant sought access to the Claimant's confidential licensing agreements with third parties to assess potential antitrust issues (FRAND compliance). The UPC Court partially granted the request, rejecting the production of external documents but compelling the Claimant to submit its own bilateral license agreement under stringent confidentiality protocols.
LiNA Medical AG v.Tonglu Qianyan Medtech Co., Ltd.
This UPC decision addresses procedural issues concerning the preservation and inspection of evidence in a medical technology dispute. The court ruled that if a defendant fails to utilize the provided CMS access code to comment on confidentiality interests after receiving an expert's detailed description, the applicant's right to proceed with disclosure is upheld. This ruling emphasizes the importance of timely digital engagement by parties involved in UPC proceedings.
GXD-Bio Corporation v.Myriad International GmbH (and associated Myriad entities)
In a significant decision, the UPC Local Division Munich revoked European Patent EP 3 346 403, which covered methods for quantifying gene expression in breast cancer tissue. The patent holder, GXD-Bio Corporation, had sued Myriad International GmbH and its subsidiaries for infringement, while the defendants filed a counterclaim for revocation. The court ultimately sided with the defendants on the revocation claim, invalidating the patent across all relevant territories. This case highlights the dual risk inherent in UPC proceedings: an infringement suit can be defeated by a successful revocation defense.
Viatris Santé v.Merz Pharmaceuticals LLC, Merz Therapeutics GmbH, Merz Pharma France
This UPC Court of Appeal decision addresses a procedural appeal concerning the admissibility of exhibits and submissions during infringement proceedings related to a pharmaceutical SPC. The court ultimately dismissed the appeal, ruling that it had become devoid of purpose because the underlying matter—the provisional measures application—had already been decided in favor of the appellant (Viatris). This highlights the importance of assessing legal interest when determining whether an action warrants adjudication under UPC rules.
IMI Hydronic Engineering Deutschland GmbH v.Belparts Group N.V.
In a procedural order concerning revocation and infringement actions, the UPC Court of First Instance addressed IMI Hydronic Engineering's request for Belparts Group to provide security for costs. IMI argued that Belparts was economically vulnerable, citing losses in 2023. However, the court dismissed the request, emphasizing that the burden of proof rests on the applicant. The decision highlights the strict evidentiary requirements necessary to successfully obtain security for costs proceedings within the UPC framework.
Polidoro S.p.a. v.Bekaert Combustion Technology B.V.
Polidoro S.p.a. successfully sued Bekaert Combustion Technology for infringing its patent covering a specific type of premixed burner used in condensation boilers. The UPC Local Division Mannheim found infringement, leading to the granting of cease and desist orders against the Defendants across several UPCA member states. Although the initial claims were successful, the court also dismissed the counterclaim filed by the Defendants seeking revocation of the patent. This case highlights the dual nature of UPC proceedings, where infringement can be established while a revocation defense is simultaneously rejected.
Huawei Technologies Co. Ltd. v.TP-Link Systems Inc., TP-Link Deutschland GmbH, TP-Link Enterprises France SARL, TP-LINK Enterprises Netherlands B.V., TP-Link Italia S.R.L., TP-LINK Enterprises Nordic AB, Lianzhou International Co., Ltd.
This UPC Board of Appeal decision addresses a procedural motion regarding document access in ongoing infringement and revocation proceedings involving Huawei and TP-Link concerning patent EP 3 678 321. TP-Link sought access to confidential documents, which the Local Division partially granted with a deadline. Huawei appealed this order, arguing against the disclosure. The Board of Appeal ultimately granted suspensive effect to Huawei's appeal, effectively halting the document disclosure until further review.
Unnamed Applicant v.Abbott Diabetes Care Inc.
This UPC CFI decision addressed a request for access to the case file of an ongoing provisional measures action (UPC_CFI_830/2025). An unnamed applicant, claiming to represent a competitor in the CGM field, sought access to conduct an FTO analysis. The Court ultimately denied this request, emphasizing that vague claims of 'specific interest' are insufficient and that procedural integrity must be maintained, especially in fast-tracked proceedings.
Sanofi SA as successor of Sanofi Mature IP v.STADAPHARM GmbH a.o.
In a significant ruling, the UPC Local Division Munich revoked European Patent 2 493 466 in its entirety. The patent, which covered a novel anti-tumoral use of cabazitaxel (marketed as JEVTANA), was found invalid across several key member states. Consequently, all associated infringement actions brought by Sanofi against generic manufacturers like STADAPHARM were dismissed. This case highlights the vulnerability of patents facing prior national challenges and underscores the UPC's role in enforcing or nullifying IP rights.
Sanofi SA as successor of Sanofi Mature IP a.o. v.Reddy Pharma SAS
In a significant pharmaceutical case, the UPC Local Division Munich revoked European Patent 2 493 466, which covered a novel anti-tumoral use of cabazitaxel. The revocation was based on prior findings of invalidity concerning the patent's scope and obviousness. Consequently, all associated infringement claims brought by Sanofi against generic manufacturers like Reddy Pharma were dismissed. This decision underscores the powerful impact of national invalidation proceedings on UPC rights.
Sanofi SA as successor of Sanofi Mature IP v.Zentiva France
In a significant pharmaceutical case, the UPC Local Division Munich revoked European Patent 2 493 466 concerning the anti-tumoral use of cabazitaxel. The revocation was based on prior invalidation proceedings in France, which demonstrated how national court decisions can directly impact patent validity within the unified system. Consequently, all associated infringement actions brought by Sanofi against generic manufacturers like Zentiva were dismissed.
ASUS Technology Licensing Inc. v.Guangdong OPPO Mobile Telecommunications Corp. Ltd
This UPC decision addressed a security for costs application filed by multiple defendants against ASUS Technology Licensing Inc., the claimant. The core issue revolved around the difficulty of enforcing cost judgments in Taiwan, where the claimant is based. Although the Defendants argued that enforcement risk was substantial due to Taiwanese legal uncertainties, the Court ultimately ordered ASUS to provide EUR 200,000 in security for costs. This ruling highlights the UPC's pragmatic approach to procedural fairness while balancing the need to protect parties against non-enforceable claims.
Sanofi SA as successor of Sanofi Mature IP a.o. v.Reddy Pharma SAS
In a significant ruling concerning pharmaceutical patents, the UPC Local Division Munich revoked European Patent 2 493 466. This patent covered a novel anti-tumoral use of cabazitaxel, which was marketed under the brand name JEVTANA by Sanofi. The revocation decision immediately dismissed all associated infringement actions brought by Sanofi against generic competitors like Reddy Pharma SAS. This case underscores the powerful effect of successful revocation proceedings within the UPC framework.
Sanofi SA as successor of Sanofi Mature IP v.Zentiva France
In a significant pharmaceutical case, the UPC Local Division Munich revoked European Patent 2 493 466 concerning the anti-tumoral use of cabazitaxel. The revocation decision effectively dismissed the concurrent infringement actions brought by Sanofi against generic manufacturers like Zentiva. This ruling underscores the power of the UPC to enforce patent validity across multiple jurisdictions, even when national court decisions regarding invalidity are involved.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.